Reducing Central Line Infections in Pediatric and Neonatal Patients
- First Online:
- 942 Downloads
The stakes for the prevention of central line associated bloodstream infections (CLABSIs) have increased dramatically over the past decade. Over the past 10 years, the rate of CLABSI in the pediatric population has dropped markedly due to the significant investment in this initiative. Although there has been a substantial increase in studies on CLABSIs, difficulties in studying CLABSIs have limited the quality of the evidence produced. These difficulties include challenges in the sample size required to complete trials, pressure from external regulatory forces to reduce CLABSI rates, and challenges in defining CLABSIs. The definition of CLABSI is continuously being updated to improve the misclassification bias inherent in defining CLABSI. This is especially relevant given the stress placed on decreasing health-care-associated infections and the negative consequences associated if unsuccessful. In order to prevent CLABSIs, pediatric and neonatal intensive care units have formed bundles of basic evidenced-based strategies leading to effective reduction of CLABSIs. These basic bundles have been modified for spread to other nonintensive care areas, also yielding great results. However, additional therapies above the basic bundle have yielded mixed results, and more research is needed to understand the cost effectiveness of these therapies in the setting of decreasing CLABSI rates. As a goal, a “getting to zero” CLABSI rate should be set, but it may not be possible without significant resource allocation.
KeywordsCatheter-related infections Central venous catheterization Health-care-associated infections Intensive care unit Neonatal Pediatrics
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.Kohn LT, Corrigan JM, Donaldson MS. National Research Council. To err is human: Building a safer health system. Washington, DC: The National Academies Press; 2000.Google Scholar
- 2.Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections—United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243–8.Google Scholar
- 3.• 111th Congress Public Law 148. An act entitled The Patient Protection and Affordable Care Act. 2010. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/content-detail.html. Accessed 23 Jan 2013. This document is the actual law that was enacted with the purpose of decreasing the number of uninsured and reducing health-care cost, along with improving health-care outcomes and delivery.
- 4.•• Miller MR, Niedner MF, Huskins WC, Colantuoni E, Yenokyan G, Moss M, et al. National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Central Line-Associated Bloodstream Infection Quality Transformation Teams. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics. 2011;128(5):e1077–83. This is the follow-up study showing the success of a multicenter effort to eradicate CLABSIs in the PICU. It also describes their finding regarding CHGIS used at some of their centers.PubMedCrossRefGoogle Scholar
- 6.•• Dudeck MA, Horan TC, Peterson KD, Allen-Bridson K, Morrell G, Pollock DA, Edwards. JR. National Healthcare Safety Network (NHSN) Report, Data Summary for 2010, Device-associated Module. http://www.cdc.gov/nhsn/datastat.html. Accessed 23 Jan 2013. The most recent publication of HAIs data from NHSN.
- 10.PubMed [Internet]. Bethesda (MD): National Library of Medicine (US). Available from: http://www.ncbi.nlm.nih.gov/pubmed/. Accessed 23 Jan 2013.
- 11.• Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA. 2009;301(12):1231–41. This study represents the largest multicenter adult trial of CHGIS dressing. It is especially relevant because it was performed after the application of basic bundle strategy and the sites had low baseline rates.PubMedCrossRefGoogle Scholar
- 13.• Rosenthal VD, Ramachandran B, Villamil-Gómez W, Armas-Ruiz A, Navoa-Ng JA, Matta-Cortés L, et al. Impact of a multidimensional infection control strategy on central line-associated bloodstream infection rates in pediatric intensive care units of five developing countries: findings of the International Nosocomial Infection Control Consortium (INICC). Infection. 2012;40(4):415–23. The first published study of this multicenter international collaborative effort to reduce CLABSIs in the PICU.PubMedCrossRefGoogle Scholar
- 14.•• National Healthcare Safety Network, CDC. NHSN Patient Safety Component Manual: 4.Central Line-Associated Bloodstream Infection (CLABSI) Event Guidelines and procedures for monitoring CLABSI. January 2013. Available from http://www.cdc.gov/nhsn/TOC_PSCManual.html. Accessed 23 Jan 2013. This is the most recent and widely adopted definition for CLABSI from the CDC.
- 15.• Niedner MF. National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Patient Care FOCUS Group. The harder you look, the more you find: Catheter-associated bloodstream infection surveillance variability. Am J Infect Control. 2010;38(8):585–95. This is the first study to look at the variability among different sites that is present when collecting surveillance data for the NHSN even in the light of a formalized definition for CLABSI.PubMedCrossRefGoogle Scholar
- 17.•• Miller MR, Griswold M, Harris 2nd JM, et al. Decreasing PICU catheter associated bloodstream infections: NACHRI’s quality transformation efforts. Pediatrics. 2010;125:206–13. The first published study of this multicenter national collaborative effort to reduce CLABSIs in the PICU.PubMedCrossRefGoogle Scholar
- 20.• Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008;36(9):e1–e12. This article describes the multicenter international collaborative effort to reduce HAIs.PubMedCrossRefGoogle Scholar
- 21.• Rosenthal VD, Lynch P, Jarvis WR, Khader IA, Richtmann R, Jaballah NB, et al. Apisarnthanarak A; International Nosocomial Infection Control Consortium members. Socioeconomic impact on device-associated infections in limited-resource neonatal intensive care units: findings of the INICC. Infection. 2011;39(5):439–50. The first published study of this multicenter international collaborative effort to reduce CLABSIs in the NICU.PubMedCrossRefGoogle Scholar
- 22.•• National Association of Children's Hospitals and Related Institutions (NACRHI). Hematology/Oncology Central Line Associated Blood Stream Infections Collaborative. November 2012. http://www.childrenshospitals.net/AM/Template.cfm?Section=Hematology_oncology&Template=/TaggedPage/TaggedPageDisplay.cfm&TPLID=249&ContentID=64510. Accessed 20 January 2013. This document is the most updated information from the NACHRI hematology/oncology collaborative effort to reduce CLABSIs.
- 24.• Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012;40(1):11–7. The publication is the a priori planned economic analysis of CHGIS from the largest adult multicenter CHGIS trial.PubMedCrossRefGoogle Scholar
- 26.Longtin J, Seah C, Siebert K, McGeer A, Simor A, Longtin Y, et al. Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009. Antimicrob Agents Chemother. 2011;55(6):2999–3001.PubMedCrossRefGoogle Scholar
- 31.Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol. 2000;18(6):1269–78.PubMedGoogle Scholar
- 35.• Lin MY, Hota B, Khan YM, Woeltje KF, Borlawsky TB, Doherty JA, et al. CDC Prevention Epicenter Program. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA. 2010;304(18):2035–41. This study assessed the variability among different sites that is present when collecting surveillance data for the NHSN, as compared with a computer algorithm.PubMedCrossRefGoogle Scholar
- 38.•• O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–93. The most recent evidence-based recommendations from the federal United States advisory committee on the best practices for preventing CLABSIs.PubMedCrossRefGoogle Scholar